Lori Preuit Dorer’s Post

🎙️ Spotlight on Early-Onset Parkinson's: A Patient's Perspective Nichola Gokool recently spoke with Cathy Molohan, diagnosed with early-onset Parkinson's in 2011, now an advocate for the inclusion and, more importantly, understanding of patient experiences in trial design and treatment options. Learn about Cathy's journey being diagnosed at just 38, and how patient voices like hers are shaping the future of clinical research. https://lnkd.in/enS7T-Kq #ParkinsonsDisease #PatientsFirst #PatientVoice #ParexelBiotech

🎙️ Spotlight on Early-Onset Parkinson's: A Patient's Perspective Nichola Gokool recently spoke with Cathy Molohan, diagnosed with early-onset Parkinson's in 2011, now an advocate for the inclusion and, more importantly, understanding of patient experiences in trial design and treatment options. Learn about Cathy's journey being diagnosed at just 38, and how patient voices like hers are shaping the future of clinical research. https://lnkd.in/eyT9VdwC #ParkinsonsDisease #PatientsFirst #PatientVoice #ParexelBiotech

🎙️ Spotlight on Early-Onset Parkinson's: A Patient's Perspective Nichola Gokool recently spoke with Cathy Molohan, diagnosed with early-onset Parkinson's in 2011, now an advocate for the inclusion and, more importantly, understanding of patient experiences in trial design and treatment options. Learn about Cathy's journey being diagnosed at just 38, and how patient voices like hers are shaping the future of clinical research. https://lnkd.in/epcU2xHs #ParkinsonsDisease #PatientsFirst #PatientVoice #ParexelBiotech

🎙️ Spotlight on Early-Onset Parkinson's: A Patient's Perspective Nichola Gokool recently spoke with Cathy Molohan, diagnosed with early-onset Parkinson's in 2011, now an advocate for the inclusion and, more importantly, understanding of patient experiences in trial design and treatment options. Learn about Cathy's journey being diagnosed at just 38, and how patient voices like hers are shaping the future of clinical research. https://lnkd.in/e46pTdpY #ParkinsonsDisease #PatientsFirst #PatientVoice #ParexelBiotech

🎙️ Spotlight on Early-Onset Parkinson's: A Patient's Perspective Nichola Gokool recently spoke with Cathy Molohan, diagnosed with early-onset Parkinson's in 2011, now an advocate for the inclusion and, more importantly, understanding of patient experiences in trial design and treatment options. Learn about Cathy's journey being diagnosed at just 38, and how patient voices like hers are shaping the future of clinical research. https://lnkd.in/e5ciTa_4 #ParkinsonsDisease #PatientsFirst #PatientVoice #ParexelBiotech

🎙️ Spotlight on Early-Onset Parkinson's: A Patient's Perspective Nichola Gokool recently spoke with Cathy Molohan, diagnosed with early-onset Parkinson's in 2011, now an advocate for the inclusion and, more importantly, understanding of patient experiences in trial design and treatment options. Learn about Cathy's journey being diagnosed at just 38, and how patient voices like hers are shaping the future of clinical research. https://lnkd.in/eWNuTuhj #ParkinsonsDisease #PatientsFirst #PatientVoice #ParexelBiotech

🎙️ Spotlight on Early-Onset Parkinson's: A Patient's Perspective Amber McAllister recently spoke with Cathy Molohan, diagnosed with early-onset Parkinson's in 2011, now an advocate for the inclusion and, more importantly, understanding of patient experiences in trial design and treatment options. Learn about Cathy's journey being diagnosed at just 38, and how patient voices like hers are shaping the future of clinical research. https://lnkd.in/gSm7Y96z #ParkinsonsDisease #PatientAdvocacy #PatientVoice #ParexelBiotech

🎙️ Spotlight on Early-Onset Parkinson's: A Patient's Perspective Amber McAllister recently spoke with Cathy Molohan, diagnosed with early-onset Parkinson's in 2011, now an advocate for the inclusion and, more importantly, understanding of patient experiences in trial design and treatment options. Learn about Cathy's journey being diagnosed at just 38, and how patient voices like hers are shaping the future of clinical research. https://lnkd.in/eWqvXrTx #ParkinsonsDisease #PatientAdvocacy #PatientVoice #ParexelBiotech

Dealing with progressive MS can be overwhelming, but emerging therapies are opening new doors. On 20 Sep at ECTRIMS Patient Community Day, let’s uncover these opportunities together. Join by registering today➡️ buff.ly/3YtV4s1 #ECTRIMS2024 #MS #MultipleSclerosis

Essential tremor —what is it ? ❓ This is a question asked by thousands of people worldwide, despite it being the most common movement disorder and over eight times more prevalent than Parkinson’s disease 🌍 This is a useful video for those who want to learn more about ET and those who are hearing about it for the first time. Let's help spread awareness by sharing this video 📢 ET organizations in the world: The International Essential Tremor Foundation (IETF) in the USA National Tremor Foundation (NTF) in the UK To find out more about life with ET you can visit Shakey Nan Youtube channel https://lnkd.in/egNpKhGj Learn more about a breakthrough medical device against tremors - the VILIM ball 👉 www.vilimed.com #vilimball #vilimed #essentialtremors #movementdisorder #parkinsonsdiesease #essentialtremor #parkinsons #parkinson #et #assistivetechnology #notsoshakeynan #shakeynan #tremoressencial #tremor #tremors #device #medtech #assistivetech #neurologicalconditions #amazing #vibrationaltherapy #TremorRelief